Inhibrx
INBX
$34.30
Share price
0.44%
Change (1 day)
29.68%
Change (1 year)
Categories
Inhibrx (INBX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.26 B
According to Inhibrx's latest financial reports the company's total liabilities are $0.26 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Inhibrx - Total liabilities on balance sheet (from 2019 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.26 B | 13.56% |
| 2022-12-31 | $0.23 B | 137.41% |
| 2021-12-31 | $98.06 M | 43.65% |
| 2020-12-31 | $68.26 M | -43.14% |
| 2019-12-31 | $0.12 B | 77.53% |
| 2018-12-31 | $67.62 M | 70.49% |
| 2017-12-31 | $39.66 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -89.44% | 🇺🇸 USA |